Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018

References

• Fink CW. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rheumatol. 1995;22(8):1566–9.
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25:1991–4.
   PubMedGoogle Scholar
• Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations criteria for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.
   PubMed Web of Science ®Google Scholar
• Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465–82.
   PubMed Web of Science ®Google Scholar
• Petty RE, Laxer RM, Lindsley CB, Wedderburn L. Textbook of Pediatric Rheumatology. 7th ed. Philadelphia: Elsevier; 2016. p. 238–55.
   Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–8.
   PubMed Web of Science ®Google Scholar
• Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–73.
   PubMed Web of Science ®Google Scholar
• Petty RE, Laxer RM, Lindsley CB, Weddernburn LR. Textbook of Pediatric Rheumatology. 7th ed. Philadelphia: Elsevier; 2016. p. 205–67.
   Google Scholar
• Takei S. The secondary research of juvenile idiopathic arthritis using the data of the study for treatment of specific pediatric chronic diseases in Japan. Allotment Report on Study by the Ministry of Health, Labour and Welfare Grant (General Study Project for Children and Home) 2008;102–13. Japanese.
   Google Scholar
• Okamoto N, Iwata N, Umebayashi H, Okura Y, Kinjo N, Kunishima T, et al. Result of questionnaire survey on the Japanese guidance for diagnosis and primary treatment of juvenile idiopathic arthritis as a preparation for revision make. J Clin Ped Rheumatol. 2016;7:5–13.
   Google Scholar
• Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011;7(7):416–26.
   PubMed Web of Science ®Google Scholar
• Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine profile in adult-onset Still's disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol. 2016;169:8–13.
   PubMed Web of Science ®Google Scholar
• Lin YT, Wang CT, Gershwin ME, Chiang BL. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev. 2011;10(8):482–9.
   PubMed Web of Science ®Google Scholar
• van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B, et al. Anti-cyclic citrullinated peptide (anti-CCP)antibodies in children with juvenile idiopathic arthritis. J Rheumatol. 2003;30:825–8.
   PubMed Web of Science ®Google Scholar
• de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66(5):589–98.
   PubMed Web of Science ®Google Scholar
• Ansell B, Beeson M, Hall P, Bedford P, Woo P. HLA and juvenile psoriatic arthritis. Br J Rheumatol. 1993;32(9):836–7.
   PubMedGoogle Scholar
• Day TG, Ramanan AV, Hinks A, Lamb R, Packham J, Wise C, et al. Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis. Arthritis Rheum. 2008;58(7):2142–6.
   PubMedGoogle Scholar
• Olivieri I, Padula A, D'Angelo S, Scarpa R. Role of trauma in psoriatic arthritis. J Rheumatol. 2008;35(11):2085–7.
   PubMed Web of Science ®Google Scholar
• Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest. 1995;96(5):2106–12.
   PubMed Web of Science ®Google Scholar
• Zhao G, Feng X, Na A, Yongqiang J, Cai Q, Kong J, et al. Acute guttate psoriasis patients have positive streptococcus hemolyticus throat cultures and elevated antistreptococcal M6 protein titers. J Dermatol. 2005;32(2):91–6.
   PubMed Web of Science ®Google Scholar
• Vasey FB, Deitz C, Fenske NA, Germain BF, Espinoza LR. Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol. 1982;9(5):719–22.
   PubMed Web of Science ®Google Scholar
• van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis. 2006;65(12):1551–7.
   PubMed Web of Science ®Google Scholar
• Jacobs JC, Berdon WE, Johnston AD. HLA-B27-associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic, and radiographic observations in 58 patients. J Pediatr. 1982;100(4):521–8.
   PubMed Web of Science ®Google Scholar
• Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 1995;38(4):499–505.
   PubMed Web of Science ®Google Scholar
• Mulders-Manders CM, Simon A, Bleeker-Rovers CP. Rheumatologic diseases as the cause of fever of unknown origin. Best Pract Res Clin Rheumatol. 2016;30(5):789–801.
   PubMed Web of Science ®Google Scholar
• Kanetaka T, Mori M, Nishimura K, Nozawa T, Kikuchi M, Sakurai N, et al. Characteristics of FDG-PET findings in the diagnosis of systemic juvenile idiopathic arthritis. Mod Rheumatol. 2016;26(3):362–7.
   PubMed Web of Science ®Google Scholar
• Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350(9077):575–80.
   PubMed Web of Science ®Google Scholar
• Tóth E, Speer G. Febrile conditions in rheumatology. Clin Rheumatol. 2012;31(12):1649–56.
   PubMed Web of Science ®Google Scholar
• Petty RE, Laxer RM, Lindsley CB, Wedderburn L. Textbook of Pediatric Rheumatology. 7th ed. Philadelphia: Elsevier; 2016. p. 217–37.
   Google Scholar
• Petty RE, Laxer RM, Lindsley CB, Wedderburn L. Textbook of Pediatric Rheumatology. 7th ed. Philadelphia: Elsevier; 2016. p. 256–67.
   Google Scholar
• Rumsay DG, Guzman l, Rosenberg AM, Huber AM, Scuccimarri R, Shiff NJ, et al. Characteristics and course of enthesitis in a juvenile idiopathic arthritis inception cohort. Arthritis Care Res (Hoboken). 2017. doi: 10.1002/acr.23256. [Epub ahead of print]
   Web of Science ®Google Scholar
• Jaremko JL, Liu L, Winn NJ, Ellsworth JE, Lambert RGW. Diagnostic utility of magnetic resonance imaging and radiography in juvenile spondyloarthritis: evaluation of the sacroiliac joints in controls and affected subjects. J Rheumatol. 2014;41(5):963–70.
   PubMed Web of Science ®Google Scholar
• Chalom EC, Goldsmith DP, Koehler MA, Bittar B, Rose CD, Ostrov BE, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997;24(10):2031–4.
   PubMed Web of Science ®Google Scholar
• Arguedas P, Fasth A, Andersson-Gäre B. A prospective population based study on outcome of juvenile chronic arthritis in Costa Rica. J Rheumatol. 2002;29:174–83.
   PubMedGoogle Scholar
• Saurenmann RK, Levin AV, Feldman BM, Rose JB, Laxer RM, Schneider R, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum. 2007;56(2):647–57.
   PubMed Web of Science ®Google Scholar
• Kunnamo I, Kallio P, Pelkonen P. Incidence of arthritis in urban Finnish children. A prospective study. Arthritis Rheum. 1986;29(10):1232–8.
   PubMedGoogle Scholar
• Skarin A, Elborgh R, Edlund E, Bengtsson-Stigmar E. Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study. Ocul Immunol Inflamm. 2009;17(2):104–8.
   PubMed Web of Science ®Google Scholar
• Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology. 2001;108(11):2071–5.
   PubMed Web of Science ®Google Scholar
• Vannucci G, Cantarini L, Giani T, Marrani E, Moretti D, Pagnini I, et al. Glucocorticoids in the management of systemic juvenile idiopathic arthritis. Pediatr Drugs. 2013;15(5):343–9.
   PubMed Web of Science ®Google Scholar
• Uziel Y, Laxer RM, Schneider R, Silverman ED. Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study. J Rheumatol. 1996;23(5):910–8.
   PubMed Web of Science ®Google Scholar
• Ilowite NT, Sandborg CI, Feldman BM, Grom A, Schanberg LE, Giannini EH, et al. Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology. Pediatr Rheumatol. 2012;10(1):31.
   PubMedGoogle Scholar
• Woo P, Southwood TR, Prieur AM, Doré CJ, Grainger J, David J, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum. 2000;43(8):1849–57.
   PubMed Web of Science ®Google Scholar
• Gerloni V, Cimaz R, Gattinara M, Arnoldi C, Pontikaki I, Fantini F. Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology (Oxford). 2001;40(8):907–13.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Huang JL, Chao HC, Lee WY, Yang MH. A follow-up study of systemic-onset juvenile rheumatoid arthritis in children. Acta Paediatr Taiwan. 1999;40(3):176–81.
   PubMedGoogle Scholar
• Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, et al. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Rheumatology (Oxford). 2005;44(11):1383–9.
   PubMed Web of Science ®Google Scholar
• Sarma PK, Misra R, Aggarwal A. Elevated serum receptor activator of NFκB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis. Clin Rheumatol. 2008;27(3):289–94.
   PubMed Web of Science ®Google Scholar
• Petty RE, Laxer RM, Lindsley CB, Wedderburn L. Textbook of Pediatric Rheumatology. 7th ed. Philadelphia: Elsevier; 2016. p. 188–204.
   Google Scholar
• Wallace CA, Bleyer WA, Sherry DD, Salmonson KL, Wedgwood RJ. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1989;32(6):677–81.
   PubMedGoogle Scholar
• Giannini EH, Cassidy JT. Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks?. Drug Saf. 1993;9(5):325–39.
   PubMed Web of Science ®Google Scholar
• Dupuis LL, Koren G, Silverman ED, Laxer RM. Influence of food on the bioavailability of oral methotrexate in children. J Rheumatol. 1995;22(8):1570–3.
   PubMed Web of Science ®Google Scholar
• Malattia C, Martini A. Glucocorticoids in juvenile idiopathic arthritis. Ann N Y Acad Sci. 2014;1318:65–70.
   PubMed Web of Science ®Google Scholar
• Lanni S, Bertamino M, Consolaro A, Pistorio A, Magni-Manzoni S, Galasso R, et al. Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis. Rheumatology. 2011;50(9):1627–34.
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council (Australian Government). Clinical Guideline for the Diagnosis and Management of Juvenile Idiopathic Arthritis August 2009. South Melbourne: The Royal Australian College of General Practitioners; 2009.
   Google Scholar
• Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371(9617):998–1006.
   PubMed Web of Science ®Google Scholar
• Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342(11):763–9.
   PubMed Web of Science ®Google Scholar
• Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008;359(8):810–20.
   PubMed Web of Science ®Google Scholar
• Imagawa T, Yokota S, Mori M, Miyamae T, Takei S, Imanaka H, et al. Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis. Mod Rheumatol. 2012;22(1):109–15.
   PubMed Web of Science ®Google Scholar
• Yokota S, Imagawa T, Takei S, Murata T, Tomiita M, Itoh Y, et al. Guidance on using tocilizumab for juvenile idiopathic arthritis. Mod Rheumatol. 2011;21(6):563–71.
   PubMed Web of Science ®Google Scholar
• Yokota S, Mori M, Imagawa T, Takei S, Murata T, Tomiita M, et al. Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan. Mod Rheumatol. 2010;20(2):107–13.
   PubMed Web of Science ®Google Scholar
• Yokota S, Imagawa T, Murata T, Tomiita M, Itoh Y, Fujikawa S, et al. Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan. Mod Rheumatol. 2012;22(4):491–7.
   PubMed Web of Science ®Google Scholar
• Consolaro A, Giancane G, Schiappapietra B, Davi S, Calandra S, Lanni S, at al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol. 2016;14(1):23.
   PubMed Web of Science ®Google Scholar
• Miyamae T, Nemoto A, Imagawa T, Ohshige K, Mori M, Nishimaki S, et al. Cross-cultural adaptation and validation of the Japanese version of the Childhood Health Assessment Questionnaire (CHAQ). Mod Rheumatol. 2008;18(4):336–43.
   PubMed Web of Science ®Google Scholar
• Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40(7):1202–9.
   PubMed Web of Science ®Google Scholar
• Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res. 2011;63(7):929–36.
   PubMed Web of Science ®Google Scholar
• Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Koné-Paut I, et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis. 2011;70(10):1704–12.
   PubMed Web of Science ®Google Scholar
• Borte S, Liebert UG, Borte M, Sack U. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford). 2009;48(2):144–8.
   PubMed Web of Science ®Google Scholar
• Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S, de Vries LD, et al. Effects of the live attenuated measles–mumps–rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA. 2013;309(23):2449–56.
   PubMed Web of Science ®Google Scholar
• Mori M, Onodera M, Morimoto A, Kosaka Y, Morio T, Notario GF, et al. Palivizumab use in Japanese infants and children with immunocompromised conditions. Pediatr Infent Dis J. 2014;33(11):1183–5.
   PubMed Web of Science ®Google Scholar
• Takei S. Juvenile idiopathic arthritis. Nihon Rinsho. 2014;72:399–403.
   PubMedGoogle Scholar
• Japan Society for Tuberculosis Prevention Committee and Treatment Committee. Guidelines for treatment of latent tuberculosis infection. Kekkaku. 2013;88:497–512.
   Google Scholar
• Drafting Committee for Hepatitis Management Guidelines and the Japan Society of the Hepatology. JSH guidelines for the management of hepatitis B virus infection. Hepatol Res. 2014;44(Suppl. 1):1–58.
   Google Scholar
• Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016;68(3):566–76.
   PubMed Web of Science ®Google Scholar
• Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2016;75(3):481–9.
   PubMed Web of Science ®Google Scholar
• Nakagishi Y, Shimizu M, Kasai K, Miyoshi M, Yachie A. Successful therapy of macrophage activation syndrome with dexamethasone palmitate. Mod Rheumatol. 2014;26:1–620.
   Web of Science ®Google Scholar
• Soriano ME, Nicolosi L, Bernardi P. Desensitization of the permeability transition pore by cyclosporin a prevents activation of the mitochondrial apoptotic pathway and liver damage by tumor necrosis factor-alpha. J Biol Chem. 2004;279(35):36803–8.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford). 2007;46(6):1015–19.
   PubMed Web of Science ®Google Scholar
• American academy of pediatrics section on rheumatology and section on ophthalmology: guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 1993;92:295–6.
   PubMed Web of Science ®Google Scholar
• Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143(4):647–55.
   PubMed Web of Science ®Google Scholar
• Rosenberg AM, Oen KG. The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum. 1986;29(6):797–800.
   PubMed Web of Science ®Google Scholar
• Cimaz RG, Fink CW. The articular prognosis of pauciarticular onset juvenile arthritis is not influenced by the presence of uveitis. J Rheumatol. 1996;23:357–9.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Michels H, Schumacher C, Kopp I, Neudorf U, Niehues T, et al. Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int. 2012;32(5):1121–33.
   PubMed Web of Science ®Google Scholar